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Post procedure headache in patients
treated for neurovascular arteriovenous
malformations and aneurysms using
endovascular therapy
Sabrina Khan1* , Faisal Mohammad Amin1, John Hauerberg2, Markus Holtmannspötter3,
Julie Falkenberg Petersen1, Zainab Fakhril-Din1, David Gaist4,5 and Messoud Ashina1
Abstract
Background: Though endovascular therapy (EVT) is increasingly applied in the treatment of intracranial vascular
lesions, little is known about the effect of EVT on post-procedure headache. We aimed to investigate the
prevalence of headache in patients who have undergone EVT for cerebral arteriovenous malformations (AVMs) and
aneurysms.
Methods: A total of 324 patients underwent EVT treatment for aneurysms and AVMs at the Danish National
Hospital from January 2012 to December 2014. We applied strict exclusion criteria in order to minimize the
effect of other factors on headache occurrence, e.g., craniotomy. Eligible subjects were phone-interviewed
using a purpose-developed semi-structured questionnaire. Headaches were classified according to ICHD-III
beta criteria.
Results: The 59 patients underwent treatment of aneurysms (n = 43), cranial dural fistulas (n = 11), and AVMs
(n = 5). There was a significant increase in overall headache (p = 0.017) and tension-type headache (TTH) (p = 0.012)
within the first 3 months after EVT compared to 1 month before EVT. However, at interview time (median 2.5 years
post-EVT), the increase in overall headache, migraine, and tension-type headache was not statistically significant. A
minority of patients experienced headaches for the first time within 3 months of their EVT (migraine 4, TTH 10). At
interview time, 50 % of these new headaches still persisted.
Conclusion: Our results suggest a temporary increase in headache in the first 3 months after EVT, which
normalizes over time. Clinicians may use this knowledge to better inform their patients of functional outcomes
after their EVT procedure.
Keywords: Endovascular therapy, Arteriovenous malformation, Aneurysm, Headache, Post procedure, Risk
Background
Endovascular treatment (EVT) of intracranial vascular
lesions as aneurysms or arteriovenous malformations
(AVMs) has been increasingly applied in the last de-
cades. Evidence suggests a reduction of post-treatment
mortality and morbidity with the transition from open
surgery to EVT [1]; however, functional outcomes such
as headache after EVT have received only little attention.
These vascular lesions may predispose to headache in
their own right [2, 3], and several studies describe head-
ache as a presenting symptom of both conditions [4, 5].
What is less known, is how this headache is affected by
endovascular treatment procedures, and the expected
time frame of headache resolution. Current studies in
this field are contradictory, some showing headache im-
provement after EVT, others worsening of preexisting
headaches [6–9]. Furthermore, it is unknown whether
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the treatment itself may induce headache in a patient
without previous headache.
From a clinical perspective, uncovering any risk of
post treatment headache and the temporal evolution of
such a headache is important for optimal counseling of
patients with treatment demanding vascular lesions.
The aim of the present study was to investigate the
prevalence of headache in patients with intracranial aneu-
rysms and AVMs after EVT, and to uncover whether EVT
treatment predisposes to onset of new headache. For this
purpose we retrospectively assessed headache characteris-
tics in a cohort of patients with AVMs and aneurysms
who had undergone EVT at a single institution.
Methods
Patients and data collection
Using a computerized registry maintained by the
Department of Radiology, we identified all patients who
underwent EVT for cerebral AVMs and aneurysms at a
tertiary referral center at Rigshospitalet (the Danish
National Hospital), Copenhagen, Denmark between
January 2012 and December 2014. The first author
assessed the medical records of all identified cases and
based on this information, excluded those fulfilling one
or more of the following exclusion criteria: 1) EVT
undergone for conditions other than AVM and aneu-
rysms, 2) non-EVT treatment of vessel malformation,
e.g., open surgery, 3) multiple EVT treatments, 4) mul-
tiple records for the same patient, 5) other intracranial
illnesses, 6) head trauma resulting in unconsciousness
and hospitalization, 7) aphasia, or no command of
Danish or English, 8) aged below 18 years at time of
EVT, and 9) unreachable after 5 efforts.
The remaining eligible patients were interviewed via
telephone using a purpose-developed semi-structured
questionnaire aimed at eliciting any history of headache
as well as possible headache after EVT. Headache status
was established for the following time periods: (i) 1 year
before EVT; (ii) 1 month before EVT; (iii) 3 months
after EVT; and (iv) at time of interview. The semi-
structured interview allowed for diagnosis of headaches
according to the International Classification of Headache
Disorders 3 beta version. Headaches where classified as
migraine (with and without aura), tension-type head-
ache, and “overall headache”. Overall headache included
migraine, tension-type headache, probable migraine,
probable tension-type headache, cluster headache, and
headaches that could not be classified due to lack of in-
formation. The first author and two medical students
trained by the first author conducted all interviews in
the period of August 2014 to February 2016.
The Committee on Health Research Ethics, Capital
Region approved the study. All patients provided written
informed consent.
Statistical analysis
Frequencies and percentages were calculated for categor-
ical variables and medians and range were calculated for
continuous variables. For comparisons of categorical
data we used McNemars test. All p-values were two-
sided and we considered p-values below 0.05 to be
statistically significant. All analyses were performed
using IBM® SPSS® Statistics version 23.
Results
A total of 830 patients were identified in the register. Of
these patients, 324 had undergone EVT for aneurysms (n
= 239) or AVMs (n= 85) (Fig. 1). The AVM group com-
prised patients that had undergone embolization for vari-
ous malformations including arteriovenous fistulas, spinal
dural arteriovenous fistulas, and dural arteriovenous fis-
tulas (DAVFs). After application of exclusion criteria, a
total of 59 eligible subjects were included in the study (43
treated for aneurysms, 16 treated for AVMs). Median age
at time of EVT was 57 years (range: 30–87 years). Median
time from EVT procedure to interview was 2.5 years
(range: 1.2–3.8 years). Clinical and demographic charac-
teristics of study participants are outlined in Table 1.
Patients treated for aneurysms underwent coiling,
stenting, coiling and stenting combined, and placement
of web-devices (table 1). Fifteen of the aneurysms had
ruptured, 28 were unruptured. Patients treated with
aneurysm coiling (n = 26) received standard antithrom-
botic care after EVT, which in Denmark consists of
aspirin treatment for 2 months. Patients where aneu-
rysms were treated with stent placement (n = 11), were
prescribed aspirin for 6 months along with an additional
antiplatelet medication for the first 3 months.
AVMs were treated with embolization solely (2 partial
occlusions, 3 complete occlusions), while DAVFs were
treated with embolization or embolization and coiling
combined (2 partial occlusions, 9 complete occlusions).
The most common localizations of vascular malforma-
tions, fistulas, and aneurysms were the internal carotid
arteries and the basilar artery (Fig. 2).
Headache status before and after EVT
A similar number of patients experienced overall head-
aches 3 months after EVT compared with 1 year before
the procedure (31 versus 32 patients; 23 treated for
aneurysms, 8 treated for AVMs) (Fig. 3, Table 2). All but
one patient with migraine continued to experience
migraine attacks post-EVT (9 versus 8 subjects). Slightly
more subjects experienced TTH 3 months after EVT
compared with the year before the procedure (20 versus
24 subjects, p = 0.5). However, none of the above com-
parisons were statistically significant. Extending the
post-EVT window of comparison from 3 months to
“time of interview” (on average 2.5 years after EVT) had
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little impact on TTH (20 versus 19 subjects), while for mi-
graine headaches; a larger albeit not statistically significant
reduction was observed (9 versus 6 subjects, p = 0.5).
We also compared patients’ headache status 1 month
before EVT with 3 months after EVT, as an expres-
sion of peri-procedural headache status. Here we
found an increase in overall headache (19 versus 31
subjects, p = 0.017), tension-type headache (12 versus
24 subjects, p = 0.012), and migraine (4 versus 8
subjects, p = 0.3) within the first 3 months after EVT.
At interview time, there was still an increase in over-
all headache (19 versus 27 subjects, p = 0.1; 19 treated
for aneurysms, 8 treated for AVMs), migraine (4 versus 6
subjects, p = 0.7) and tension-type headache (12 versus 19
subjects, p = 0.1), though none of these results reached
statistical significance.
We also asked patients about headaches experienced
at any time prior to EVT, as a measure of pre-
intervention lifetime headache prevalence in this patient
group. Compared to headache experienced at interview
time, there was a significant decrease in overall headache
(45 versus 27 subjects, p < 0.001) and migraine (15 versus
6 subjects, p = 0.022).
In patients treated for aneurysms and who reported
headache after EVT, coiling was the most prevalent
procedure followed by stenting, both at 3 months after
EVT (23 subjects with overall headache; coiling = 13,
stent = 7) and at time of interview (19 subjects with overall
headache; coiling = 11, stent = 5, coiling + stent = 12).
Headache frequency before and after EVT
Comparing migraine frequency before and after EVT,
there was an increase in headache days during the first
3 months post-procedure (31–45 headache days per
3 months) compared to both 1 year, and 1 month before
EVT (6–12 headache days per month) (Table 3). How-
ever, at interview time, the frequency had regressed
towards 1–5 headache days per month.
Headache frequency of TTH showed a similar pattern
over time, although far less pronounced, with an
increase in headache days the first 3 months after EVT
(6–12 headache days per 3 months) and a regression to
pre-EVT frequency at time of interview (1–5 headache
days per month).
De novo headaches after EVT
In all, 10 of 24 subjects with TTH post-procedure expe-
rienced this headache type for the first time in their lives
during the first 3 months after EVT (Fig. 4). By the time
Fig. 1 Study enrolment
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of interview, only 5 patients still experienced these
headaches.
First time ever attacks of migraine were experienced
by 4 subjects in the 3 month period after EVT, and two
of these patients still experienced migraine attacks at
time of interview (2.1 and 2.6 years after EVT,
respectively), with a median frequency of 25–45 head-
ache days per 3 months.
There was no correlation between side of procedure
and headache laterality (data not shown).
Discussion
Existing studies on post-EVT headache in patients with
aneurysms and AVMs show diverging results, generally
favoring improvement of headache after treatment [8, 9].
Where an exacerbation was found, it was typically
reported to be temporary and to resolve within days or
months [6–8, 10]. Nevertheless, however short-lived
these headaches may be, the majority still defy the strict
time frame defined by the International Headache
Classification, stating that headaches attributed to intra-
cranial endovascular procedures develop within seconds
and resolve within 24 h of the procedure [2]. For this
reason, it has been suggested that ICHD-III beta criteria
may not properly reflect clinical reality in terms of the
temporal aspect of a possible headache after EVT [11].
Our data support this notion, as we found an increase in
headache prevalence within the first three months after
EVT compared to one month before EVT. At time of
interview, this increase had regressed towards prevalence
estimates similar to those reported in studies of the gen-
eral Danish population for subjects with migraine. For
tension-type headache, the prevalence also decreased
over time, but was generally lower than corresponding
numbers from Danish population-studies.
Possible reasons for these temporary headaches after
EVT include local inflammation due to placement of
foreign objects such as stents, coils or glue, and mechan-
ical stimulation of the arterial wall [6, 8, 10]. Other ex-
planations include changes in flow dynamics after EVT
causing the release or stress of a venous overload [5, 11],
possibly leading to post-procedural headache. This
mechanism may be particularly true of AVMs.
Fig. 2 Localization of treated aneurysms, arteriovenous malformations, and dural arteriovenous fistulas. VA = vertebral artery, BA = basilar artery,
ICA = internal carotid artery, MCA =middle cerebral artery, ACOM= anterior communicating artery, PCOM= posterior communicating artery, PCA =
posterior cerebral artery. Another 16 localizations were distributed as follows: Left MCA + ICA = 1; bilateral ICA = 1; ophthalmic artery = 1; cavernous
sinus = 1; left sigmoid sinus = 1, and unspecified locations (n = 11)
Table 1 Clinical and demographic characteristics of
endovascularly treated patients
Characteristics
Median age and range 57,4 (30–87)
Males 21
Right-handed 50
Median height and range (cm) 169 (154 – 203)
Median weight and range (kg) 74 (48 – 106)
Median BMI and range (kg/m2) 25 (17–39)
Vascular disorder
- Aneurysms 43
- AVMs 5
- DAVFs 11
Aneurysm procedures
- Coiling 26
- Stenting 11
- Coiling + stenting 4
- Web device 2
AVM procedures
- Embolization 5
DAVF procedures
- Embolization 9
- Embolization + coiling 2
AVM arteriovenous malformation, DAVF dural arteriovenous fistula
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A sub-group analysis of our cohort suggests that post-
EVT headache may be more prevalent after coiling of an-
eurysms, followed by stent-placements. This is in line with
previous studies, suggesting that use of a stent device is
associated with increase of headache [6, 8]. It also seems
that post-procedure headache is more prevalent in pa-
tients treated for aneurysms compared to AVMs. How-
ever, aneurysms are overrepresented in our cohort, and
for this reason, along with generally small numbers in this
subgroup analysis, we acknowledge that no firm conclu-
sions can be made based on our tentative findings.
A potential correlation between aneurysms, AVMs and
headache is no new concept, and studies have suggested
that for patients harboring these vascular anomalies,
headache may be more prevalent than in the general
population [3, 4, 12]. Based on epidemiological studies
of the general Danish population, the lifetime cumulated
prevalence for both sexes is 16–18 % for migraine and
78 % for tension-type headache [13, 14]. With this study,
we report a lifetime prevalence of 25 % for migraine, and
46 % for tension-type headache, suggesting that patients
with aneurysms and AVMs are predisposed specifically
to migraine. The pathophysiological mechanism respon-
sible for this increase in migraine prevalence may be re-
lated to the very angioarchitecture of these vascular
conditions, which, per definition, is abnormal. Lebedeva
et al. suggested that increased sensory input from sen-
sory nerve endings around the aneurysms may sensitize
the central nervous system decreasing the threshold for
developing spontaneous migraine attacks [4]. Other pos-
sible mechanisms predisposing to headache include local
thrombosis, meningeal inflammation, expansion and in-
flammation of the aneurysm, and bleeding within the
vessel wall; ultimately activating nociceptive C-fibers of
the trigeminal nerve [4, 15]. For AVMs, Galletti et al.
showed the location of AVMs to be significantly associ-
ated with migraine-like headache presentation, leading
the authors to suggest that hemodynamic and structural
Fig. 3 Headache status before and after endovascular treatment. Numbers represent patients. Overall headache includes migraine with aura,
migraine without aura, tension-type headache, probable migraine, probable tension-type headache, cluster headache, and unclassified headache.
Red dotted line represents the endovascular procedure
Table 2 Comparison of 59 patients’ headache status before and after endovascular treatment
Anytime before (n) Interview time (n)a P-value
Overall headache 45 27 0.0003*
Migraine 15 6 0.022*
Tension-type headache 27 19 0.077
1 year before (n) Interview time (n) Change (%) P-value
Overall headache 32 27 −16 0.302
Migraine 9 6 −33 0.453
Tension-type headache 20 19 −5 1.000
1 month before (n) 3 months after (n) Change (%) P-value
Overall headache 19 31 +63 0.017*
Migraine 4 8 +100 0.289
Tension-type headache 12 24 +100 0.012*
aMedian time from EVT procedure to interview: 2.5 years
*P-values under 0.05
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changes caused by AVMs in the occipital lobe may trig-
ger spreading depression and thus migraine [5].
For 1-year prevalence of headache, our data support
the general knowledge of migraine prevalence, with 15 %
reporting migraine in our cohort (9 out of 59 subjects
within the last year prior to EVT) versus 10 % in the
general Danish population [14]. The 1-year prevalence
of tension-type headache is smaller in our cohort, with a
prevalence of 34 % versus 74 % in the general Danish
population [14]. In contrast to our results, Lebedeva et
al. found a significant increase in the 1-year prevalence
of migraine without aura in subjects with aneurysms
(42.2 %) compared to controls (8.8 %), but no significant
change in tension-type headache (19.6 % versus 23.1 %)
[4]. However, important methodological differences exist
between the studies, which impede direct comparisons.
Subjects in the study by Lebedeva et al. were interviewed
at time of admission to hospital upon rupture of their
aneurysm. As thunderclap headache is the common pres-
entation of aneurysms, the painful condition of the sub-
jects at time of interview may have biased their recall of
headaches. Conversely, in our study we interviewed pa-
tients after EVT, and it can be argued that the overall suc-
cess of the procedure as seen from a patient perspective,
may have influenced the subjects’ recollection of their
headaches, e.g., with a successful procedure leading to less
focus on or recall of concomitant headache. It can be ar-
gued that the inclusion of 15 patients with ruptured aneu-
rysms at the time of EVT could influence our results in so
far that patients with this condition can experience head-
aches up to 1 month after the event [2]. However, in a post
hoc analysis we excluded these 15 patients, and found simi-
lar results (1 month before vs. 3 months after, migraine: 3
subjects vs 6 subjects; TTH: 7 subjects vs 19 subjects).
In our cohort, a fraction of patients experienced onset of
new headache after EVT. Three months post EVT, 10 sub-
jects experienced tension-type headache, and 4 subjects ex-
perienced migraine; these numbers declined to 5 and 2
subjects, respectively, at time of interview. Albeit small in
numbers, these de novo headaches may still be indicative
of a causal relationship between EVT and headache, espe-
cially when considering the cohort median age of 57 years.
Migraine onset in this age group is highly unusual [16].
We also note that some patients experience only tempor-
ary headache after EVT while others progress to persistent
headache. Schwedt and colleagues suggest that central
sensitization may contribute to the persistence of any such
new headache following EVT [8].
In terms of classification of these post-procedural
headaches, any de novo headache occurring for the first
time after EVT is a secondary headache and would
optimally be classified as a “headache attributed to
Table 3 Headache frequency before and after endovascular treatment
Headache day score in relation to endovascular procedure
1 year before 1 month before 3 months after At interview time
Migraine 2 (1 – 7)
n = 9
2.5 (2 – 3)
n = 4
5 (1 – 7)
n = 8
1 (1 – 4)
n = 6
Tension-type headache 3 (1 – 7)
n = 20
1 (1 – 3)
n = 12
2 (0 – 7)
n = 24
1 (0 – 4)
n = 19
Frequency represented as a headache score corresponding to following intervals: 0 = no headache
days, 1 = 1–5 headache days, 2 = 6–12 headache days, 3 = 13–24 headache days, 4 = 25–30 headache days, 5 = 31–45 headache days, 6 = 46–60 headache days,
and 7 =more than 60 headache days. Headache scores listed as median and range
Fig. 4 Distribution of de novo headaches and known headache after endovascular treatment. Numbers represent patients.
TTH = tension-type headache
Khan et al. The Journal of Headache and Pain  (2016) 17:73 Page 6 of 8
intracranial endovascular procedure” [2]. However, as
per the current definition, this headache resolves within
24 h after EVT, thus not fitting the temporal pattern of
headache observed in our cohort. By comparison, the
classification for “acute headache attributed to craniot-
omy” allows for headache duration of up to 3 months
after surgical intervention. We believe this time frame to
be more appropriate for our results, which suggested an
increased prevalence of headache for the first 3 months
after EVT that thereafter regresses over time. Faced with
these classification complexities, we chose to classify all
post-procedural headaches as primary headaches,
although we fully acknowledge that de novo headaches
with a causal and temporal relation to EVT can be con-
ceived as secondary headaches.
Strengths of this study include a subject group com-
prised of two vascular conditions both treated with the
introduction of foreign bodies including coils, glue, and
stenting. Subjects were consecutively included at a single
tertiary referral center. All interviews were conducted by
medical specialists trained in diagnosing headaches ac-
cording to the ICHD-III beta, using purpose-developed
questionnaires and through direct, telephone contact.
Also, to describe the evolution of headaches over time,
we specifically collected information on subjects’ head-
aches at multiple time-points before and after EVT.
Finally, we pooled subjects with aneurysms and AVMs,
as these conditions both comprise vascular anomalies
and may predispose to headache by way of similar
angioarchitectural mechanisms.
Because of its retrospective nature, recall bias is an in-
herent limitation of our study. Remembering character-
istics of headaches occurring several years prior to EVT
may pose a considerable challenge to some patients,
which can result in some degree of headache diagnosis
inaccuracy. Also, we recognize the limitation of our
sample size. However, the relatively small sample size
was partly due to a conscious choice on our behalf, i.e.,
our adherence to strict exclusion criteria so as to
minimize bias introduced by inclusion of other condi-
tions or treatments than the ones under study. Nonethe-
less, we cannot rule out the impact of clinical diversity
on our results due to inter- and intra-group heterogene-
ities (e.g., aneurysms versus AVMs and a large aneurysm
versus a small aneurysm, ruptured versus unruptured
aneurysms, etc.), which we could only address in a lim-
ited fashion, i.e., in analyses stratified by type of vascular
malformation (aneurysm vs. AVM).
For headache after EVT, we lack information on the
time period between 3 months after EVT and up to the
time of the interview, which took place 2.5 years after
EVT on average. This would have provided us with a
more detailed understanding of the evolution of a post--
procedural headache.
Finally, one could argue that headache in the wake of
such serious and potentially debilitating conditions is
only a minor concern. Nevertheless, we do find it im-
portant to investigate functional outcomes after EVT in
this patient group, particularly for those patients who
are successfully treated for their primary condition, but
where EVT results in other negative consequences such
as persistent headache, which indeed may be highly dis-
abling for the affected individual.
Conclusion
In conclusion, our results indicate that EVT performed in
subjects with intracranial aneurysms and AVMs leads to a
temporary increase in headache for the first three months
after EVT. Over time, this increase in headache status
regresses towards prevalence estimates resembling those
of the general Danish population. Also, new onset of
headache in a smaller fraction of subjects experienced in
the first three months after EVT resolves over time in half
of the cases. This knowledge of a potentially short-lived
headache after EVT holds significant clinical value, as it
may lead to better counseling of subjects about to undergo
EVT and optimization of treatment efforts in cases where
post-procedural headache does occur. Finally, we tenta-
tively suggest that the current ICHD-3 beta definition of
headache attributed to intracranial vascular procedures
may be sub-optimal, as our results show that any such
headache may well last more than the allowed 24 h.
Prospective studies are warranted to closely follow
headache patterns within shorter time intervals after EVT.
This will allow us to further uncover even small exacerba-
tions in headache, which inadvertently may affect the
quality of life for the individual patient, however tempor-
ary these changes may prove to be.
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